Denali Therapeutics Inc.
Modulators of eukaryotic initiation factor 2B, compositions and methods

Abstract:

The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and methods of making and using thereof.